Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643

被引:21
|
作者
Li, Guolin [1 ,2 ,3 ,4 ]
Brocker, Chad N. [1 ]
Xie, Cen [1 ]
Yan, Tingting [1 ]
Noguchi, Audrey
Krausz, Kristopher W. [1 ]
Xiang, Rong [5 ,6 ]
Gonzalez, Frank J. [1 ]
机构
[1] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Murine Phenotyping Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] Hunan Normal Univ, Coll Life Sci, Lab Aging Biochem, Changsha 410081, Hunan, Peoples R China
[4] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China
[5] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China
[6] Cent S Univ, Sch Life Sci, Changsha, Hunan, Peoples R China
基金
美国国家卫生研究院;
关键词
fibrate drugs; hypolipidemia; hypophagia; PPAR; Wy-14643; PPAR-ALPHA; ENERGY-EXPENDITURE; BODY-WEIGHT; FOOD-INTAKE; EXPRESSION; AGONIST; MOUSE; MICE; HOMEOSTASIS; STEATOSIS;
D O I
10.1111/jgh.14046
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and AimPeroxisome proliferator-activated receptor alpha (PPAR) is a molecular target of various fibrate drugs clinically used to lower serum lipids. However, the tissue-specific functions of PPAR remain to be elucidated. This study aimed to explore the tissue-specific functions of PPAR in response to Wy-14643. MethodsA hepatocyte-specific Ppara knockout mouse line was used to explore the impact of hepatic PPAR activity on the systemic response to treatment with the potent PPAR agonist Wy-14643. ResultsWy-14643 mainly activated hepatic PPAR and regulated the expression of PPAR target genes in liver. Hepatic Ppara disruption abolished the triglyceride lowering effects of Wy-14643, prevented agonist-induced hypophagia, and ablated PPAR target gene response in the liver. ConclusionsThese findings indicate that Wy-14643 treatment mainly activates hepatic PPAR, and the hypolipidemic and hypophagic effects of Wy-14643 are dependent on PPAR activation within hepatocytes.
引用
收藏
页码:1138 / 1145
页数:8
相关论文
共 50 条
  • [2] Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
    Liu, Sihao
    Hatano, Ben
    Zhao, Minghui
    Yen, Chen-Chung
    Kang, Kihwa
    Reilly, Shannon M.
    Gangl, Matthew R.
    Gorgun, Cem
    Balschi, James A.
    Ntambi, James M.
    Lee, Chih-Hao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (02) : 1237 - 1247
  • [3] WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells
    Hwang, Yong Pil
    Won, Seong Su
    Jin, Sun Woo
    Lee, Gi Ho
    Pham, Thi Hoa
    Choi, Jae Ho
    Kang, Keon Wook
    Jeong, Hye Gwang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
  • [4] Expression of the Human UGT1 Locus in Transgenic Mice by WY-14643 and Implications on Drug Metabolism Through Peroxisome Proliferator-Activated Receptor (PPAR) α Activation
    Senekeo-Effenberger, Kathy
    Chen, S.
    Brace-Sinnokrak, E.
    Bonzo, J. A.
    Yueh, M-F.
    Argikar, U.
    Kaedine, J.
    Trottier, J.
    Remmel, R. P.
    Ritter, J. K.
    Barbier, O.
    Tukey, R. H.
    FASEB JOURNAL, 2008, 22
  • [5] Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
    Basso, Paulo Jose
    Sales-Campos, Helioswilton
    Nardini, Viviani
    Duarte-Silva, Murillo
    Freitas Alves, Vanessa Beatriz
    Bonfa, Giuliano
    Rodrigues, Cassiano Costa
    Ghirotto, Bruno
    Lazo Chica, Javier Emilio
    Nomizo, Auro
    de Barros Cardoso, Cristina Ribeiro
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] Molecular Mechanism of Peroxisome Proliferator-Activated Receptor α Activation by WY14643: a New Mode of Ligand Recognition and Receptor Stabilization
    Bernardes, Amanda
    Souza, Paulo C. T.
    Muniz, Joao R. C.
    Ricci, Clarisse G.
    Ayers, Stephen D.
    Parekh, Nili M.
    Godoy, Andre S.
    Trivella, Daniela B. B.
    Reinach, Peter
    Webb, Paul
    Skaf, Munir S.
    Polikarpov, Igor
    JOURNAL OF MOLECULAR BIOLOGY, 2013, 425 (16) : 2878 - 2893
  • [7] Protective Effects of Peroxisome Proliferator-Activated Receptor-α Agonist, Wy14643, on Hypoxia/Reoxygenation Injury in Primary Rat Hepatocytes
    Chen, Ke
    Li, Yuan-Hai
    Xu, Si-Qi
    Hu, Sheng-Hong
    Zhang, Lei
    PPAR RESEARCH, 2012, 2012
  • [8] Peroxisome proliferator-activated receptor γ and metabolic disease
    Willson, TM
    Lambert, MH
    Kliewer, SA
    ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 341 - 367
  • [9] Peroxisome proliferator-activated receptor α mediates the effects of high-fat diet on hepatic gene expression
    Patsouris, D
    Reddy, JK
    Müller, M
    Kersten, S
    ENDOCRINOLOGY, 2006, 147 (03) : 1508 - 1516
  • [10] Hepatic Peroxisome Proliferator-Activated Receptor Alpha Dysfunction in Porcine Septic Shock
    Vandewalle, Jolien
    Garcia, Bruno
    Timmermans, Steven
    Vanderhaeghen, Tineke
    Van Wyngene, Lise
    Eggermont, Melanie
    Dufoor, Hester
    Van Dender, Celine
    Halimi, Fellanza
    Croubels, Siska
    Herpain, Antoine
    Libert, Claude
    CELLS, 2022, 11 (24)